Every other year, the leading cancer survivorship researchers gather to share information on the needs of those who have gone through cance...
599
0Like
CURE invited Diane Gambill, PhD, a CURE advisory board member, to share her thoughts on advancements in blood cancers highlighted at the 201...
511
0Like
Shared decision making is a collaborative process for building relationships between patients and providers, using both scientific evidence ...
596
0Like
Mark Roll’s pulmonary doctor was so astonished to learn that his stubborn cough was due to lung cancer that he tracked Roll down on a ...
579
0Like
Megan Silianoff described her treatment for ovarian cancer, first in a phone call with the adoption agency in 2011, and then later when she ...
626
0Like
OK, spoiler alert. If you plan to see the movie, don’t read this blog.
Last night I went to see The Fault in our Stars, the story of ...
598
0Like
No one, unless they have been there, can explain what it’s like to be in pain 24/7. When I began researching a neuropathy feature for...
794
0Like
CURE invited Diane Gambill, PhD, a CURE advisory board member, to share her thoughts on advancements in lymphoma highlighted at the 2014 ann...
817
0Like
Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of certain anti-cancer treatments. How these drugs affect t...
505
0Like
While non-small cell lung cancer (NSCLC) has a reputation as a hard-to-treat cancer, several studies presented at ASCO may help researchers...
459
0Like
